Fatima Karwandyar

For too long, minority groups have been underrepresented in clinical trials, and the past year of living amidst a pandemic illustrated why this is a problem. The pandemic heightened awareness among the general public of health disparities among minority populations. Early on it took center stage when the data demonstrated that people of color were